Compound ID | 1388
Class: Quinazolinone (PBP1 and 2a inhibitor)
Spectrum of activity: | Gram-positive |
Details of activity: | MRSA |
Institute where first reported: | Area of Biochemistry and Molecular Biology, University of La Rioja, Logroño, Spain |
Year first mentioned: | 2019 |
Highest developmental phase: | Preclinical |
Chemical structure(s): | |||||||||||
|
|
External links: | |
Citation: | https://aac.asm.org/content/64/1/e01344-19 |